Sign in
Taking peopleNo phase

Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease

Key facts

Who runs it
Can Tho University of Medicine and Pharmacy
Where
Vietnam1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
80 people, planned
Started
1 Oct 2024
Planned end
30 May 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Bismuth quadruple therapy
  • Triple therapy with PPI + Amoxicillin + Metronidazole
Record updated
2 December 2025

Who can take part

Age
5 years to 15 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Diagnosed with gastritis or peptic ulcer disease by upper gastrointestinal endoscopy or histopathology
  • Meets diagnostic criteria for Helicobacter pylori infection
  • Parent or legal guardian provides consent for the child to participate in the study

Who cannot take part

  • Use of antibiotics or bismuth within the past 4 weeks, or use of antacids, H2-receptor antagonists, or proton pump inhibitors within the past 2 weeks
  • Allergic to any of the medications in the treatment regimen
  • Failure to return for follow-up visits after treatment

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 5 and 15 years old?

This trial is currently available in Vietnam.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if including bismuth in the treatment helps heal stomach and duodenal ulcers caused by Helicobacter pylori (H. pylori) in children.

Read full original descriptionShow less

The main questions it aims to answer are:

* Does a treatment plan with bismuth work better than a plan without bismuth to clear the infection? * Is the bismuth plan more cost-effective while still safe and effective?

Researchers will compare two treatment groups to see which works better. Participants will:

* Take one of the two assigned treatment plans (with or without bismuth) for the standard treatment duration * Visit the clinic for checkups and tests to confirm infection clearance and monitor side effects * Keep a diary of symptoms, medication use, and any side effects

The 2 groups in the trial

  • Bismuth quadruple therapyTreatment being tested

    Patients in this arm will receive PPI, Amoxicillin, Metronidazole, and Bismuth for 14 days, with doses adjusted according to weight and age.

  • Triple therapy with PPI + Amoxicillin + MetronidazoleTreatment being tested

    Patients in this arm will receive PPI, Amoxicillin, Metronidazole for 14 days, with doses adjusted according to weight and age.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Study on the Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease
Criteria questions
Built from NCT07260006, who can take part
Record updated
2 December 2025